Tag Archives: What’s

Alexion’s beating forecasts with Soliris-to-Ultomiris switch. So what’s up with its pesky stock price?

In its push to backstop sales of blockbuster Soliris, Alexion has touted its better-than-expected success at switching patients to follow-up drug Ultomiris. But if switching to the newer med is going so well, why are investors so wary? Forty percent of Soliris patients treated for adult paroxysmal nocturnal hemoglobinuria (PNH) have switched over to the… Read More »

What’s killing the world’s great chefs?

Chef-to-the-stars Justin Bull seemed to have everything to live for, just like the other celebrity chefs he followed whose deaths police said had “no suspicious circumstances”. Like Jeremy Strode, like Darren Simpson, like Anthony Bourdain. The body of 46-year-old Bull was found inside his smart cafe Huxton’s in the seaside Sydney suburb of Bronte, which… Read More »